|
5th Edition Drug Safety Symposium 2026 - Middle East Chapter
hits:119 Date:11/06/25
5th Edition Drug Safety Symposium 2026 – Middle East Chapter Set to Take Pharmacovigilance to a New Level
January 21st – 22nd, 2026 | Grand Mercure Dubai Airport Hotel, UAE
After four highly successful editions across India and Dubai, Eminence Group proudly announces the return of its flagship event, the 5th Edition Drug Safety Symposium 2026 – Middle East Chapter, to be held on January 21st & 22nd, 2026 at the Grand Mercure Dubai Airport Hotel, Dubai.
Recognized as one of the most influential pharmacovigilance (PV) gatherings in the region, the symposium continues its mission to advance patient safety and regulatory excellence across the Middle East. The 2026 edition, themed “Pharmacovigilance 360°: Building Patient Safety from Clinical Trials to Post-Market,” will deliver a comprehensive exploration of drug safety across the entire product lifecycle, from clinical research to real-world application.
Expanding the Scope: From Compliance to Culture
This year, the symposium goes beyond traditional post-marketing surveillance to cover clinical trial safety, pre-approval submissions, lifecycle risk management, and digital transformation in PV. It aims to build a culture of proactive, patient-centric safety, moving from checklist-based compliance to strategic, continuous readiness.
Unlike conventional conferences, the Drug Safety Symposium is built around interactive, practice-driven engagement. Delegates can expect live challenge sessions, mock inspections, hands-on workshops, and real-world case studies that translate regulatory theory into practical implementation.
Key Sessions and Highlights
The two-day event features a rich mix of keynotes, panel discussions, and immersive workshops, including:
* Inspection Readiness: Turning the audit room into your strongest compliance story, highlighting practical strategies for building a culture of continuous inspection readiness.
* Regulators’Viewpoint: Policies, practice & expectations, a multi-country panel featuring representatives from the UAE, Saudi Arabia, Egypt, Jordan, Kuwait, Oman and other GCC regulators, providing direct insights into regional harmonization and regulatory priorities.
* Academic Viewpoint: From protocol to patient, exploring the integration of safety frameworks into regional clinical research and academic trials.
* Hands-On Workshop: “Strengthening ADR Reporting Systems in the Middle East: From Compliance to Culture”, a two-hour practical session designed to enhance local reporting systems, one of the region’s most critical PV challenges.
* Session on Rare Diseases: Addressing the region’s readiness for orphan drug safety, following SFDA’s proactive orphan designations.
* Real-World Evidence: Turning data into decisions - As real-world data becomes the new cornerstone of drug safety, this session explores how regional stakeholders can harness real-world evidence to uncover safety insights, support regulatory submissions, and drive smarter, data-backed decisions across the product lifecycle.
Global Participation and Regional Impact
The symposium will feature speakers and participants from more than 10 countries, including leaders from Novartis, Pfizer, AstraZeneca, Hikma, Julphar, and Tabuk, alongside senior representatives from national regulatory authorities.
“Our goal is to make pharmacovigilance practical, proactive, and truly patient-focused,” said Ms. Guneet Hayer, Managing Director, Eminence Group. “The 5th Edition Drug Safety Symposium 2026 – Middle East Chapter isn’t just another conference; it’s a working forum where regulators, industry, and academia collaborate to build stronger, smarter, and more resilient safety systems for the region.”
By fostering open dialogue between regulators, industry experts, and technology innovators, the 5th Edition Drug Safety Symposium 2026 – Middle East Chapter aims to create tangible outcomes, including frameworks for ADR reporting, stronger industry–regulator collaboration, and practical models for risk and crisis management.
About Eminence Group Ventures
Eminence Group Ventures is a leading organizer of high-impact pharma and life sciences conferences across India and the Middle East, known for connecting global expertise with regional insight.
Event Details:
DATE: January 21st – 22nd, 2026
VENUE: Grand Mercure Dubai Airport Hotel, UAE
For speaker opportunities, partnerships, and delegate registration, contact:
Suryansh@eminencemedia.in | www.drugsafetysymposium.com
|
中文
